Roche Reaffirms 2026 Outlook Despite Weak Vabysmo Sales, Strong Swiss Franc Written By sheeba farhat24 July 2026 9:46 PM ISTBasel: Swiss ​drugmaker Roche confirmed its 2026 outlook ​on Thursday after first-half sales fell slightly in Swiss ​franc terms, dragged down by a...
USFDA Approves GSK's Cancer Drug Jideytro After USD 10.6 Billion Nuvalent Deal Written By sheeba farhat23 July 2026 10:13 PM ISTLondon: GSK said on Wednesday the U.S. FDA approved its drug to treat a form of lung cancer, nearly two months after the British drugmaker acquired...
Jazz Pharma's Lung Cancer Drug Zepzelca Fails Late-Stage Trial, Faces Regulatory Uncertainty Written By sheeba farhat15 Jun 2026 11:15 PM ISTBengaluru: Jazz Pharmaceuticals said on Friday its lung cancer drug Zepzelca failed to meet the main goal of improving overall survival in a...
Mankind Pharma Appoints Nilesh Kulkarni as Group HR Head in Leadership Reshuffle Written By Parthika Patel12 Jun 2026 11:43 PM ISTNew Delhi: Mankind Pharma has appointed Nilesh Kulkarni as the Head of Human Resource Functions for the Mankind Pharma Group as part of a strategic...
Pfizer Reviews Germany Investments Amid Concerns Over Drug Pricing Reforms Written By sheeba farhat12 Jun 2026 10:19 PM ISTLondon: Pfizer is reviewing ​the timing and scope of planned investments in Germany, CEO Albert Bourla ​said in a letter to Chancellor Friedrich Merz,...
USFDA Expands Organon's Tofidence Use for Cancer-Related Immune Reaction, Severe COVID-19 Written By sheeba farhat11 Jun 2026 5:59 PM ISTBengaluru: Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded use of its arthritis drug, a biosimilar to...
Roche Sticks with Major Germany Investment While Eli Lilly, Boehringer Cut Spending Written By sheeba farhat10 Jun 2026 8:35 PM ISTFrankfurt: The Swiss pharmaceutical and diagnostics ​giant Roche said ​it is sticking to its planned ​investments in Germany, unlike some of its...
Roche Strikes USD 2.3 Billion Nurix Deal for Blood Cancer Drug Bexobrutideg Written By sheeba farhat9 Jun 2026 8:03 PM ISTZurich: Swiss pharmaceutical giant Roche has entered an exclusive licensing and collaboration agreement with Nurix Therapeutics of up to USD 2.3...
Roche Chairman Slams US Tariff Threats as 'Cold-Blooded Blackmail', Flags Rising Protectionism Risks Written By sheeba farhat7 Jun 2026 10:00 AM ISTZurich: The chairman of Swiss pharmaceutical giant Roche hit out at U.S. tariff policies on Thursday, likening them to "blackmail", and said...
Roche Obesity Drug Enicepatide Delivers 22.7% Weight Loss in Mid-Stage Trial, Challenges Wegovy, Zepbound Written By sheeba farhat6 Jun 2026 11:16 PM ISTBengaluru: Roche said on Friday that patients lost 22.7% of their ​body weight in a mid-stage ​trial of its dual-acting experimental obesity drug,...
Roche Asked to Revise Tecentriq SC Phase IV Trial Plan for Lung Cancer in India Written By Parthika Patel9 May 2026 4:16 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the CDSCO, has directed Roche Products (India) Private Limited to recalculate the...
Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry Written By sheeba farhat25 April 2026 5:06 PM ISTNew Delhi: Swiss ‌drugmaker Roche's first-quarter sales dropped by 5%, it said on Thursday, citing unfavourable foreign exchange effects that offset...
